OncLive: Dr. Mesa on Emerging Therapies in Myelofibrosis

September 24, 2020

Ruben A. Mesa, MD, director of the Mays Cancer Center, discusses emerging therapies in myelofibrosis. Watch the interview.

Targeted Oncology: Treatment approaches become more individualized as field of myelofibrosis advances

September 21, 2020

In this interview, Ruben Mesa, MD, director of the Mays Cancer Center, shares highlights from his presentation on the role of JAK inhibitors in myelofibrosis during the first annual Texas Virtual MPN Workshop and Meeting. Read the story.

Congressional Hispanic Caucus Institute: Global Pandemics: Innovation for early detection and a coordinated response system

September 18, 2020

Ruben Mesa, MD, FACP, director of the Mays Cancer Center, was a guest on a panel during the Congressional Hispanic Caucus Institute’s 2020 Leadership Conference.

OncLive: Dr. Mesa on the Emergence of JAK Inhibitors in Myelofibrosis

September 15, 2020

In this interview, Ruben A. Mesa, MD, director of the Mays Cancer Center, discusses the emergence of JAK inhibitors in myelofibrosis. Watch the interview. 

The Cancer Letter: Mays Cancer Center receives renewal of NCI designation

September 14, 2020

This news brief highlights the renewal of the Mays Cancer Center as an NCI-Designated Cancer Center. Read the story.

Dr. Laura Tenner named 2019 ASCO Advocacy Champion

September 9, 2020

The American Society of Clinical Oncology (ASCO) has recognized Laura Tenner, MD, MPH, as one of ASCO’s 2019 Advocacy Champions at the Senator’s Club Level for her dedication to educating lawmakers on important policies that ensure patients have access to high quality cancer care. Her advocacy accomplishments include the ASCO Advocacy Summit on Capitol Hill, […]